Leptomeningeal lymphoma: perspectives on management.
D000970:Antineoplastic Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D001099:Arachnoid; D003561:Cytarabine / Q000008:administration & dosage / Q000627:therapeutic use; D006801:Humans; D007278:Injections, Spinal; D008223:Lymphoma / Q000175:diagnosis / Q000473:pathology / Q000628:therapy*; D008577:Meningeal Neoplasms / Q000175:diagnosis / Q000473:pathology / Q000628:therapy*; D008727:Methotrexate / Q000008:administration & dosage / Q000627:therapeutic use; D010841:Pia Mater; D013852:Thiotepa / Q000008:administration & dosage / Q000627:therapeutic use
D000970:Antineoplastic Agents; D003561:Cytarabine; D013852:Thiotepa; D008727:Methotrexate